Sustained pulmonary vasodilation after inhaled nitric oxide for hypoxic pulmonary hypertension in swine

Journal of Pediatric Surgery

Volumn 31, Issue 3, 1996, Pages 389-393

  Emil, Sherif ^a,b   Kanno, Sotaro ^a,b   Berkeland, Joel ^a,b   Kosi, Mahmoud ^a,b   Atkinson, James ^a,b,c  

^a Childrens Hospital ^*

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOXIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SWINE; VASODILATATION;

EID: 0029865946     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(96)90744-7     Document Type: Article

References (27)

1. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526, 1987
2. Ignarro LJ, Buga GM, Wood KS, et al: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269, 1987
3. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan At, et al: Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338:1173-1174, 1991
4. Girard C, Lehot JJ, Pannetier JC, et al: Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 77:880-883, 1992
5. Rossaint R, Falke KJ, Lopez F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399-405, 1993
6. Roberts JD, Polaner DM, Lang P, et al: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:818-819, 1992
7. Kinsella JP, Neish SR, Shaffer E, et al: Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:819-820, 1992
8. Kinsella JP, Neish SR, Dunbar-Ivy D, et al: Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 123:103-108, 1993
9. Finer NN, Etches PC, Kamstra B, et al: Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose response. J Pediatr 124:302-308, 1994
10. Roberts JD, Lang P, Bigatello LM, et al: Inhaled nitric oxide in congenital heart disease. Circulation 87:447-453, 1993
11. Wessel DL, Adatia I, Thompson JE, et al: Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 22:930-938, 1994
12. Bigatello LM, Hurford WE, Kacmarek RM, et al: Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 80:761-770, 1994
13. Puybasset L, Stewart T, Rouby JJ, et al: Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome. Anesthesiology 80:1254-1267, 1994
14. Winberg P, Lundell BP, Gustafsson LE: Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease. Br Heart J 71:282-286, 1994
15. Puybasset L, Rouby JJ, Mourgeon E, et al: Inhaled nitric oxide in acute respiratory failure: Dose response curves. Intensive Care Med 20:319-327, 1994
16. Journois D, Pouard P, Mauriat P, et al: Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 107:1129-1135, 1994
17. Cioffi WG, Ogura H: Inhaled nitric oxide in acute lung disease. New Horizons 3:73-85, 1995
18. Shah N, Jacob T, Exler R, et al: Inhaled nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg 29:1010-1014, 1994
19. Emil S, Kosi M, Berkeland J, et al: Severity of hypoxia predicts response to nitric oxide in a porcine pulmonary hypertension model. J Pediatr Surg 30:930-936, 1995
20. Gerlach H, Rossaint R, Pappert D, et al: Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23:499-502, 1993
21. Ignarro L: Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65:1-15, 1989
22. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991
23. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012, 1993
24. Archer SL, Tolins JP, Raij L, et al: Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium-derived relaxing factor. Biochem Biophys Res Commun 164:1198-1205, 1989
25. Minnard EA, Shou J, Naama H, et al: Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129:142-148, 1994
26. Robertson FM, Offner PJ, Ciceri DP, et al: Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129:149-156, 1994
27. Ogura H, Offner PJ, Saitoh D, et al: The pulmonary effect of nitric oxide synthase inhibition following endotoxemia in a swine model. Arch Surg 129:1233-1239, 1994